Business
The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium
CERRITOS, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United
About this update from The Oncology Institute, Inc.
[{"type":"text","content":"CERRITOS, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate on the “Next Frontier - Value Based Care for Sub-Capitation/Specialties” panel at the Nephron 2nd Annual Physician Enablement Symposium on Thursday, September 22 at 9:00am EST. About The Oncology Institute, Inc. Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.7 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 90+ employed clinicians and more than 700 teammates in over 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com. Contacts Media The Oncology InstituteJulie [email protected](562) 735-3226 x 88806 ReviveMichael [email protected](615) 760-4542 Investors Solebury TroutMaria [email protected] \nSource: Toi Management, LLC","length":3624,"tagName":"div"}]